Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GARY BERMAN

Allopathic & Osteopathic Physicians Allergy & Immunology Clinical & Laboratory Immunology

NPI
1609836121
CMS profile
299081
Location
MINNEAPOLIS, MN

General Payments · PY2018–2024

$280,790.99

  • Reported across 440 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$8,894.40

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $7,700.00 2
Travel and Lodging $820.26 4
Food and Beverage $374.14 9

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
PFIZER INC. $7,169.76 4
Moderna TX, Inc. $1,006.32 9
Eli Lilly and Company $700.00 1
GlaxoSmithKline, LLC. $18.32 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $39,029.59 94
PY2019 $111,618.36 193
PY2020 $69,760.01 80
PY2021 $16,974.19 15
PY2022 $19,748.29 17
PY2023 $14,766.15 26
PY2024 $8,894.40 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Eli Lilly and Company $700.00 03/14/2024 Consulting Fee Undisputed 01/23/2026 1134994982 CMS
GlaxoSmithKline, LLC. $18.32 09/17/2024 Food and Beverage Undisputed 01/23/2026 1116255903 CMS
ModernaTX, Inc. $27.87 09/14/2024 Food and Beverage Undisputed 01/23/2026 1152558334 CMS
ModernaTX, Inc. $328.95 09/14/2024 Travel and Lodging Undisputed 01/23/2026 1152558344 CMS
ModernaTX, Inc. $77.97 09/14/2024 Travel and Lodging Undisputed 01/23/2026 1152558350 CMS
ModernaTX, Inc. $265.53 09/14/2024 Travel and Lodging Undisputed 01/23/2026 1152558352 CMS
ModernaTX, Inc. $120.00 09/14/2024 Food and Beverage Undisputed 01/23/2026 1152558368 CMS
ModernaTX, Inc. $45.00 09/14/2024 Food and Beverage Undisputed 01/23/2026 1152558370 CMS
ModernaTX, Inc. $30.00 09/14/2024 Food and Beverage Undisputed 01/23/2026 1152558372 CMS
ModernaTX, Inc. $81.00 09/14/2024 Food and Beverage Undisputed 01/23/2026 1152558374 CMS
ModernaTX, Inc. $30.00 09/14/2024 Food and Beverage Undisputed 01/23/2026 1152558376 CMS
PFIZER INC. $7,000.00 02/22/2024 Consulting Fee Undisputed 01/23/2026 1130900946 CMS
PFIZER INC. $147.81 04/02/2024 Travel and Lodging Undisputed 01/23/2026 1130900951 CMS
PFIZER INC. $14.53 06/06/2024 Food and Beverage Undisputed 01/23/2026 1130918866 CMS
PFIZER INC. $7.42 12/03/2024 Food and Beverage Undisputed 01/23/2026 1131063422 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.